Works matching IS 02692813 AND DT 2003 AND VI 18 AND IP 1
Results: 17
Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 77, doi. 10.1046/j.1365-2036.2003.01640.x
- By:
- Publication type:
- Article
Is a 9-month treatment sufficient in tuberculous enterocolitis? A prospective, randomized, single-centre study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 85, doi. 10.1046/j.1365-2036.2003.01599.x
- By:
- Publication type:
- Article
Botulinum toxin in the therapy of gastrointestinal motility disorders.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 1, doi. 10.1046/j.1365-2036.2003.01598.x
- By:
- Publication type:
- Article
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 141, doi. 10.1046/j.1365-2036.2003.01612.x
- By:
- Publication type:
- Article
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 33, doi. 10.1046/j.1365-2036.2003.01613.x
- By:
- Publication type:
- Article
Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 57, doi. 10.1046/j.1365-2036.2003.01614.x
- By:
- Publication type:
- Article
Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent–invasive E. coli strains isolated from patients with Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 45, doi. 10.1046/j.1365-2036.2003.01638.x
- By:
- Publication type:
- Article
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 65, doi. 10.1046/j.1365-2036.2003.01639.x
- By:
- Publication type:
- Article
The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 151, doi. 10.1046/j.1365-2036.2003.01641.x
- By:
- Publication type:
- Article
Mitogen-activated protein kinases in chronic intestinal inflammation — targeting ancient pathways to treat modern diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 17, doi. 10.1046/j.1365-2036.2003.01642.x
- By:
- Publication type:
- Article
Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 133, doi. 10.1046/j.1365-2036.2003.01644.x
- By:
- Publication type:
- Article
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 93, doi. 10.1046/j.1365-2036.2003.01649.x
- By:
- Publication type:
- Article
A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 125, doi. 10.1046/j.1365-2036.2003.01650.x
- By:
- Publication type:
- Article
Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 117, doi. 10.1046/j.1365-2036.2003.01651.x
- By:
- Publication type:
- Article
Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 109, doi. 10.1046/j.1365-2036.2003.01656.x
- By:
- Publication type:
- Article
High-dose rabeprazole–amoxicillin versus rabeprazole–amoxicillin–metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 101, doi. 10.1046/j.1365-2036.2003.01659.x
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- 2003
- Publication type:
- Table of Contents